Exploring Ethical Dimensions of Amnioinfusions for Early Anhydramnios

Abstract: This cross-disciplinary panel aims to delve into the ethical considerations surrounding the use of amnioinfusions for early anhydramnios, a condition characterized by a deficiency of amniotic fluid during pregnancy. Amnioinfusions, a medical intervention involving the infusion of sterile saline into the amniotic cavity, have been employed to address complications associated with anhydramnios. While this technique holds promise, clinical trials are ongoing and uncertainty exists surrounding long-term perinatal outcomes, raising complex ethical questions that warrant thoughtful examination.
The proposed panel brings together experts from diverse fields, including maternal-fetal medicine, bioethics, neonatology, and a parent advocate to engage in a comprehensive discussion on the ethical dimensions of amnioinfusions in early anhydramnios, and clinical trials. Key topics to be explored include the informed consent process for pregnant individuals, potential risks and benefits associated with the procedure for both pregnant persons and fetus, and considerations related to equipoise and research ethics.
The panelists will analyze the broader implications of utilizing amnioinfusions in this context through clinical trials and ethical frameworks. Discussions will also encompass societal perspectives, ensuring a holistic examination of the ethical landscape. By fostering a multidisciplinary dialogue, this panel seeks to provide valuable insights for clinicians, ethicists, Institutional Research Board (IRB) members, and parents grappling with the ethical challenges posed by using amnioinfusions in managing early anhydramnios. Ultimately, the aim is to contribute to the development of ethical guidelines that prioritize the well-being of both pregnant individuals and their unborn children in the face of this complex medical condition and potential intervention.